Association of lipoprotein(a) with platelet aggregation and thrombogenicity in patients undergoing percutaneous coronary intervention-Reference-Cited by-同舟云学术

Association of lipoprotein(a) with platelet aggregation and thrombogenicity in patients undergoing percutaneous coronary intervention

Published:2020-08-13 Issue:5 Volume:32 Page:684-689
ISSN:0953-7104
Container-title:Platelets
language:en
Short-container-title:Platelets

Author:

Zhu Pei¹,Tang Xiao-Fang¹,Song Ying¹,Zhang Yin¹,Gao Li-Jian¹,Gao Zhan¹,Chen Jue¹,Yang Yue-Jin¹,Gao Run-Lin¹,Xu Bo¹,Yuan Jin-Qing¹^ORCID

Affiliation:

1. Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China

Funder

National Key Research and Development Program of China

Publisher

Informa UK Limited

Subject

Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/09537104.2020.1802412

Reference36 articles.

1. Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease

2. Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality

3. Genetic variants, plasma lipoprotein(a) levels, and risk of cardiovascular morbidity and mortality among two prospective cohorts of type 2 diabetes

4. Structural absorption by barbule microstructures of super black bird of paradise feathers

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aspirin use in patients with elevated lipoprotein(a): Impact on cardiovascular events and bleeding;Current Problems in Cardiology;2024-11

2. Lipoprotein(a) as a novel biomarker for predicting adverse outcomes in ischemic heart failure;Frontiers in Cardiovascular Medicine;2024-09-05

3. Impact of Elevated Lipoprotein A on Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis;Cureus;2024-05-25

4. Lipoprotein(a): an important consideration for DAPT therapy after PCI;Cardiology Journal;2024-04-26

5. Elevated High-Sensitivity C-Reactive Protein Level Enhances the Impact of Lipoprotein(a) on Platelet Reactivity in PCI Patients Treated with Clopidogrel;Clinical and Applied Thrombosis/Hemostasis;2024-01